SLNSW-Lack of EGFR mutations benefiting gefitinib treat...-TN_cdi_doaj_primary_oai_doaj_org_article_2581cdc685bc45719409ad1074ed9f58

Lack of EGFR mutations benefiting gefitinib treatment in adenocarcinoma of esophagogastric junction

Full title: Lack of EGFR mutations benefiting gefitinib treatment in adenocarcinoma of esophagogastric junction

Author/creator: Wang, Wen-Ping, Wang, Kang-Ning, Gao, Qiang, Chen, Long-Qi.

Call Numbers:

Record Identifier: TN_cdi_doaj_primary_oai_doaj_org_article_2581cdc685bc45719409ad1074ed9f58

Language: English

Formats: Articles

Publishers: England: BioMed Central Ltd

Permalink: https://collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2581cdc685bc45719409ad1074ed9f58

Articles

Articles

Export this record

Export selected records

  • Export to excel
  • Permalink

    • Export record to excel

    File type to download

    Beta version

    Record title

    Lack of EGFR mutations benefiting gefitinib treatment in adenocarcinoma of esophagogastric junction

    Record identifier

    TN_cdi_doaj_primary_oai_doaj_org_article_2581cdc685bc45719409ad1074ed9f58

    Record permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2581cdc685bc45719409ad1074ed9f58

    Share

    Lack of EGFR mutations benefiting gefitinib treatment in adenocarcinoma of esophagogastric junction

    ACCESS
    https://collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2581cdc685bc45719409ad1074ed9f58

    Lack of EGFR mutations benefiting gefitinib treatment in adenocarcinoma of esophagogastric junction

    Full title

    Lack of EGFR mutations benefiting gefitinib treatment in adenocarcinoma of esophagogastric junction

    Author / Creator

    Wang, Wen-Ping ; Wang, Kang-Ning ; Gao, Qiang ; Chen, Long-Qi

    Publisher

    England: BioMed Central Ltd

    Journal title

    World journal of surgical oncology, 2012, Vol.10 (1), p.14-14

    Record Identifier

    TN_cdi_doaj_primary_oai_doaj_org_article_2581cdc685bc45719409ad1074ed9f58

    Language

    English

    Formats

    Articles

    Publication information

    Publisher

    Subjects

    Subjects and topics

    Adenocarcinoma Adenocarcinoma - drug therapy Adenocarcinoma - genetics Adenocarcinoma - pathology Adenocarcinoma of esophagogastric junction Adult Aged Antineoplastic Agents - therapeutic use Blood Cancer therapies Care and treatment Design Epidermal growth factor receptor Esophageal Neoplasms - drug therapy Esophageal Neoplasms - genetics Esophageal Neoplasms - pathology Esophagogastric Junction - drug effects Esophagogastric Junction - pathology Exons - genetics FDA approval Federal regulation Female Gefitinib Gene mutation Gene mutations Gene therapy Genes Genomes Health aspects Humans Male Middle Aged Mutation Mutation - genetics Neoplasm Recurrence, Local - drug therapy Neoplasm Recurrence, Local - genetics Neoplasm Recurrence, Local - pathology Neoplasm Staging Prognosis Proteins Quinazolines - therapeutic use Receptor, Epidermal Growth Factor - genetics Signal transduction Single nucleotide polymorphism Smoking Stomach Neoplasms - drug therapy Stomach Neoplasms - genetics Stomach Neoplasms - pathology Studies Survival Rate Thoracic surgery

    More information

    — SCOPE AND CONTENTS

    Contents

    — ALTERNATIVE TITLES

    Full title

    — AUTHORS, ARTISTS AND CONTRIBUTORS

    Author / Creator

    Identifiers

    — PRIMARY IDENTIFIERS

    Record Identifier

    TN_cdi_doaj_primary_oai_doaj_org_article_2581cdc685bc45719409ad1074ed9f58

    Permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2581cdc685bc45719409ad1074ed9f58

    — OTHER IDENTIFIERS

    ISSN

    E-ISSN

    DOI

    How to access this item

    Online

    1 item

    How to access?

    Login with a Library card

    Full text available >

    About resource >

    View in old catalogue

    Connecting people and collections